Advanced search
Start date
Betweenand

EMU 2015/26722-8 CLARIOstar microplate reader

Grant number: 17/03042-7
Support type:Multi-user Equipment Program
Duration: May 01, 2017 - April 30, 2024
Field of knowledge:Biological Sciences - Parasitology
Principal Investigator:Carsten Wrenger
Grantee:Carsten Wrenger
Home Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Associated research grant:15/26722-8 - Drug discovery against human infectious diseases, AP.TEM
As informações de acesso ao Equipamento Multiusuário são de responsabilidade do Pesquisador responsável
EMU web page:http://cefap.icb.usp.br/core-facilities/pluma/clariostar-microplate-reader/
Tipo de equipamento:Processos Biológicos - Caracterização - Leitores de placas
Fabricante: BMG Labtech
Modelo: CLARIOstar Microplate Reader

Abstract

Infectious diseases are a threat to mankind and currently the causative pathogens are spreading geographically due to globalisation and developing drug resistance. Current resistance to chemotherapeutics is occurring to almost all pathogens and therefore new drug targets and/or novel modi of drug target efficacy is urgently needed. In this grant application the focus will be drawn on suicide drug discovery by exploiting the vitamin B1/B6 biosynthetic pathways of the human pathogens Plasmodium falciparum, the parasite responsible for predominate cases of severe malaria, and the multi-resistant bacteria Staphylococcus aureus MRSA. Compounds will be identified and designed for incorporation into pathogens' metabolism after crystal structure evaluation of the respective vitamin B1/B6 biosynthetic enzymes. Thereby the new compounds are intended to poison the respective vitamin-dependent enzyme. Counter selection will be performed against human cells as well as transgenically modified human cells which are expressing nuclear receptors for xenobiotic sensing as reporter gene chimeras. (AU)